During the past decade, Universitatsklinikum Aachen, Augenklinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Aachen, Augenklinik" are "Retinitis Pigmentosa" (2 trials), "Macular Degeneration" (1 trials), "Non Arteritic Anterior Ischemic Optic Neuropathy" (1 trials) and "Outer Retinal Degeneration" (1 trials). Many other conditions were trialed in "Universitatsklinikum Aachen, Augenklinik" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Aachen, Augenklinik" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Albumin (Human) 25%, United States Pharmacopeia (USP)" (1 trials), "Argus II Retinal Prosthesis" (1 trials), "Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified" (1 trials), "QPI-1007 Injection - 1.5 mg" (1 trials) and "QPI-1007 Injection - 3.0 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Aachen, Augenklinik" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinikum Aachen, Augenklinik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitatsklinikum Aachen, Augenklinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Aachen, Augenklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".